According to Taro Pharmaceutical's latest financial reports the company's total liabilities are $0.38 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-03-31 | $0.40 B | -12.96% |
2022-03-31 | $0.46 B | -34.65% |
2021-03-31 | $0.71 B | 207.32% |
2020-03-31 | $0.23 B | 3.25% |
2019-03-31 | $0.22 B | 0.63% |
2018-03-31 | $0.22 B | 3.18% |
2017-03-31 | $0.21 B | -13.93% |
2016-03-31 | $0.25 B | -21.69% |
2015-03-31 | $0.32 B | 21.45% |
2014-03-31 | $0.26 B | 22.31% |
2013-03-31 | $0.21 B | |
2011-12-31 | $0.22 B | 30.74% |
2010-12-31 | $0.17 B | -38.64% |
2009-12-31 | $0.28 B | -9.29% |
2008-12-31 | $0.30 B | -6.43% |
2007-12-31 | $0.33 B | -11.95% |
2006-12-31 | $0.37 B | -10.77% |
2005-12-31 | $0.42 B | 28.08% |
2004-12-31 | $0.32 B | 22.67% |
2003-12-31 | $0.26 B | 144.1% |
2002-12-31 | $0.10 B | 23.61% |
2001-12-31 | $88.62 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 25,619.24% | ๐บ๐ธ USA |
Novartis NVS | $53.19 B | 13,749.76% | ๐จ๐ญ Switzerland |
Pfizer PFE | $137.21 B | 35,624.55% | ๐บ๐ธ USA |
Merck MRK | $69.04 B | 17,875.14% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $58.82 B | 15,215.66% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $35.35 B | 9,104.45% | ๐ฎ๐ฑ Israel |